Health
UK to start HEAL-COVID trial to reduce mortality,re-admission rate among Covid survivors – BusinessLine
This will be carried out in collaboration with the Liverpool Clinical Trials Centre at the University of Liverpool and Wrexham-based clinical trial technology firm…
The United Kingdom is set to initiate a drug trial called HEAL-COVID in an effort to alleviate the mortality rate and readmission cases in patients who have previously been hospitalised with the novel coronavirus.
According to the report by Clinical Trials Arena, data collated by the UK Office for National Statistics indicated that 29 per cent of Covid-19 hospitalised patients were readmitted within six months. While more than 12 per cent died within the same period.
So, the new trial will help…
-
Noosa News17 hours agoProtest calls for shark net removal
-
General16 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News19 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General8 hours agoTeam Australia wins back-to-back Motocross of Nations titles